Curcumin against Prostate Cancer: Current Evidence.
androgen-insensitive
androgen-sensitive
apoptosis
curcumin
in vitro
in vivo
polyphenol
proliferation
prostate cancer
survival
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
received:
07
10
2020
revised:
30
10
2020
accepted:
04
11
2020
entrez:
13
11
2020
pubmed:
14
11
2020
medline:
8
9
2021
Statut:
epublish
Résumé
Cancer is a condition characterized by remarkably enhanced rates of cell proliferation paired with evasion of cell death. These deregulated cellular processes take place following genetic mutations leading to the activation of oncogenes, the loss of tumor suppressor genes, and the disruption of key signaling pathways that control and promote homeostasis. Plant extracts and plant-derived compounds have historically been utilized as medicinal remedies in different cultures due to their anti-inflammatory, antioxidant, and antimicrobial properties. Many chemotherapeutic agents used in the treatment of cancer are derived from plants, and the scientific interest in discovering plant-derived chemicals with anticancer potential continues today. Curcumin, a turmeric-derived polyphenol, has been reported to possess antiproliferative and proapoptotic properties. In the present review, we summarize all the in vitro and in vivo studies examining the effects of curcumin in prostate cancer.
Identifiants
pubmed: 33182828
pii: biom10111536
doi: 10.3390/biom10111536
pmc: PMC7696488
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Oncol. 2007 Apr;30(4):905-18
pubmed: 17332930
Phytother Res. 2011 Jul;25(7):1102-4
pubmed: 21226125
J Natl Cancer Inst. 2013 Apr 3;105(7):452-8
pubmed: 23434901
Cell Cycle. 2007 Dec 1;6(23):2953-61
pubmed: 18156803
PLoS One. 2012;7(4):e35368
pubmed: 22523587
Clin Biochem Rev. 2016 Feb;37(1):3-15
pubmed: 27057074
Prostate Cancer Prostatic Dis. 2000 Aug;3(2):84-93
pubmed: 12497104
Korean J Urol. 2015 Sep;56(9):656-65
pubmed: 26366279
Biomed Res Int. 2015;2015:413076
pubmed: 26137480
J Biol Chem. 2010 May 14;285(20):14980-9
pubmed: 20231295
J Cancer Ther. 2014 Apr 1;5(4):369-386
pubmed: 24949215
Prostate Cancer Prostatic Dis. 2010 Dec;13(4):343-9
pubmed: 20680030
APMIS. 2017 Feb;125(2):134-140
pubmed: 28120490
Mol Nutr Food Res. 2011 Nov;55(11):1666-76
pubmed: 21936051
Int J Clin Exp Pathol. 2015 Aug 01;8(8):9272-8
pubmed: 26464676
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Curr Oncol. 2010 Sep;17 Suppl 2:S25-32
pubmed: 20882128
Clin Sci (Lond). 2009 Aug 14;117(6):209-28
pubmed: 19663810
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
In Vitro Cell Dev Biol Anim. 1999 Jul-Aug;35(7):403-9
pubmed: 10462204
J Epidemiol Glob Health. 2019 Dec;9(4):217-222
pubmed: 31854162
Pharm Res. 2008 Sep;25(9):2181-9
pubmed: 18437538
J Androl. 2008 Nov-Dec;29(6):661-8
pubmed: 18676361
G3 (Bethesda). 2017 Jun 7;7(6):1731-1741
pubmed: 28413162
J Pharmacol Exp Ther. 2007 May;321(2):616-25
pubmed: 17289836
Int J Oncol. 2002 Oct;21(4):825-30
pubmed: 12239622
Cancer Cell Int. 2005 Apr 06;5(1):8
pubmed: 15813967
J Steroid Biochem Mol Biol. 2004 Oct;92(3):187-97
pubmed: 15555912
J Urol. 2002 Jul;168(1):9-12
pubmed: 12050481
Mol Cancer Ther. 2008 Sep;7(9):2609-20
pubmed: 18790744
Prostate. 2001 Jun 1;47(4):293-303
pubmed: 11398177
Int J Oncol. 2015 Dec;47(6):2064-72
pubmed: 26499200
Foods. 2017 Oct 22;6(10):
pubmed: 29065496
Carcinogenesis. 2007 Jun;28(6):1188-96
pubmed: 17151092
Genet Test Mol Biomarkers. 2018 Jan;22(1):43-50
pubmed: 29172709
J Exp Clin Cancer Res. 2015 May 15;34:46
pubmed: 25971429
Int J Oncol. 2009 May;34(5):1319-27
pubmed: 19360344
Int J Cancer. 2009 Jul 1;125(1):1-8
pubmed: 19326431
Phytochemistry. 2009 Oct-Nov;70(15-16):1696-707
pubmed: 19665152
J Mol Signal. 2007 Oct 04;2:10
pubmed: 17916240
Prostate. 2004 Jun 15;60(1):1-17
pubmed: 15129424
Cancer Res. 1983 Apr;43(4):1809-18
pubmed: 6831420
Peptides. 2009 Dec;30(12):2357-64
pubmed: 19772879
Semin Oncol. 1999 Aug;26(4):407-21
pubmed: 10482183
Cancers (Basel). 2019 Aug 01;11(8):
pubmed: 31374935
Microb Biotechnol. 2011 Nov;4(6):687-99
pubmed: 21375717
Clin Oncol (R Coll Radiol). 2013 Aug;25(8):474-82
pubmed: 23727431
Cancer Biol Ther. 2008 Sep;7(9):1427-35
pubmed: 18719366
Acta Pharmacol Sin. 2007 Mar;28(3):423-30
pubmed: 17303007
Gene. 2017 Oct 5;631:29-38
pubmed: 28843521
Mol Cancer Ther. 2003 Jan;2(1):95-103
pubmed: 12533677
Oncogene. 2013 Dec 5;32(49):5501-11
pubmed: 23752182
Pharmacogenomics. 2015;16(3):273-85
pubmed: 25712190
Cancer Res. 2007 Mar 1;67(5):1988-96
pubmed: 17332326
Invest Urol. 1979 Jul;17(1):16-23
pubmed: 447482
Prostate Cancer Prostatic Dis. 2006;9(2):147-52
pubmed: 16389264
Biomaterials. 2014 Oct;35(30):8635-48
pubmed: 25028336
Eur Urol. 2009 Jan;55(1):62-75
pubmed: 18945543
J Cell Biochem. 2019 Sep;120(9):15616-15624
pubmed: 31042325
Oncol Lett. 2016 Feb;11(2):1499-1505
pubmed: 26893768
N Engl J Med. 2011 May 5;364(18):1708-17
pubmed: 21542742
Prostate. 2011 Nov;71(15):1668-79
pubmed: 21432867
Int J Mol Sci. 2013 Oct 21;14(10):21087-113
pubmed: 24152442
Redox Biol. 2017 Aug;12:634-647
pubmed: 28391184
Int J Cancer. 1978 Mar 15;21(3):274-81
pubmed: 631930
AAPS J. 2011 Dec;13(4):606-14
pubmed: 21938566
Mol Cancer Ther. 2004 Jul;3(7):803-12
pubmed: 15252141
Cancer Chemother Pharmacol. 2017 May;79(5):985-994
pubmed: 28391351
Eur Urol. 2013 Sep;64(3):372-8
pubmed: 23506834
Oncogene. 2001 Nov 15;20(52):7597-609
pubmed: 11753638
Prostate. 1993;23(2):123-34
pubmed: 8104329
Cancer Res. 2010 Apr 15;70(8):3382-90
pubmed: 20395211
Drug Des Devel Ther. 2017 Feb 14;11:431-439
pubmed: 28243065
Int J Mol Sci. 2019 Oct 02;20(19):
pubmed: 31581661
Cancer Res. 2006 Jan 15;66(2):613-21
pubmed: 16423986
Carcinogenesis. 2012 Dec;33(12):2507-19
pubmed: 23042094
Mol Cancer. 2008 Jan 29;7:16
pubmed: 18226269
Rev Urol. 2007;9 Suppl 1:S3-8
pubmed: 17387371
Biomed Pharmacother. 2016 Dec;84:177-184
pubmed: 27657825
Hum Cell. 2020 Jul;33(3):730-736
pubmed: 32146706
Prostate. 2012 Sep 1;72(12):1317-27
pubmed: 22213130
JAMA. 2017 Jun 27;317(24):2532-2542
pubmed: 28655021
JAMA. 2005 Jul 13;294(2):238-44
pubmed: 16014598
NPJ Precis Oncol. 2017;1:
pubmed: 29202102
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
PLoS One. 2017 Jun 19;12(6):e0179587
pubmed: 28628644
Int Braz J Urol. 2009 May-Jun;35(3):354-60; discussion 361
pubmed: 19538771
Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2)
pubmed: 10881018
OMICS. 2012 Jun;16(6):289-300
pubmed: 22475723
Oncogene. 2002 Dec 12;21(57):8852-61
pubmed: 12483537
Cancer Lett. 2008 Oct 18;270(1):132-43
pubmed: 18565644
Curr Oncol. 2010 Sep;17 Suppl 2:S18-24
pubmed: 20882127
Biochem Pharmacol. 2011 Nov 1;82(9):1073-8
pubmed: 21787756
Biochem Biophys Res Commun. 1990 Dec 14;173(2):534-40
pubmed: 2260966
Urol Oncol. 2012 Jan-Feb;30(1):3-15
pubmed: 19945310
J Cell Biochem. 2003 May 1;89(1):1-5
pubmed: 12682902
Nutr Cancer. 2010;62(3):379-89
pubmed: 20358476
Cancer Prev Res (Phila). 2013 May;6(5):495-505
pubmed: 23466486
Clin Adv Hematol Oncol. 2013 Jan;11(1):14-23
pubmed: 23416859
Iran Red Crescent Med J. 2013 Apr;15(4):279-84
pubmed: 24082997
Drug Deliv. 2019 Dec;26(1):1017-1026
pubmed: 31578087
Prostate. 2007 Dec 1;67(16):1801-15
pubmed: 17935158
J Natl Cancer Inst. 1993 Mar 3;85(5):394-8
pubmed: 8433392
Drug Des Devel Ther. 2019 Nov 28;13:4021-4033
pubmed: 31819373
Int J Oncol. 2011 Mar;38(3):603-11
pubmed: 21240460
Asian J Androl. 2018 May-Jun;20(3):221-229
pubmed: 29063869
PLoS One. 2008;3(10):e3508
pubmed: 18946510
J Biochem Mol Toxicol. 2018 May;32(5):e22049
pubmed: 29485738
Nat Rev Cancer. 2001 Oct;1(1):34-45
pubmed: 11900250
J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):530
pubmed: 21823017
Nutrients. 2019 Sep 29;11(10):
pubmed: 31569529
Asian Pac J Cancer Prev. 2014;15(3):1465-70
pubmed: 24606484
Cancer Sci. 2018 Apr;109(4):1230-1238
pubmed: 29369461
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567